This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Inventor Shin Sakurai
Introduction: Shin Sakurai, an inventive mind from Choshi, Japan, has made significant contributions to the field of chemistry through his patent on a sodium salt of a disaccharide compound. With a keen focus on improving the stability of compounds, his work showcases the intersection of innovation and practical application in the pharmaceutical industry.
Latest Patents: Shin Sakurai holds a patent for his groundbreaking invention titled "Sodium salt of disaccharide compound, production method and use of same." This invention pertains to a composition that comprises a range of sodium salts represented by a specific formula, aimed at enhancing stability over time for certain sodium salts. The detailed production method not only contributes to scientific understanding but also has potential applications in various industries, particularly pharmaceuticals.
Career Highlights: Sakurai is associated with Eisai R&D Management Co., Ltd., a leading player in the pharmaceutical sector. His role within the company involves pioneering research and development, focusing on the enhancement and stability of chemical compounds that can be utilized in various therapeutic applications.
Collaborations: Throughout his career, Shin Sakurai has collaborated with notable colleagues, including Ken Furukawa and Kimihiro Matsuo. These collaborations are vital in fostering innovation, as they combine different areas of expertise to tackle complex scientific challenges.
Conclusion: As an inventor, Shin Sakurai exemplifies the spirit of innovation in the field of chemistry. His patent for the sodium salt of a disaccharide compound not only showcases his ingenuity but also represents a meaningful advancement in the development of stable chemical formulations. His work at Eisai R&D Management Co., Ltd. and collaborations with esteemed colleagues contribute to a brighter future in pharmaceutical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
